Fluorescence PCR
-
KRAS 8 Mutations
Iyi kit inoitirwa in vitro qualitative yekuona 8 shanduko mumakodoni 12 uye 13 eK-ras gene mune yakatorwa DNA kubva kune vanhu parafini-yakamisikidzwa pathological zvikamu.
-
Human EGFR Gene 29 Mutations
Iyi kit inoshandiswa ku in vitro yemhando yekuona shanduko dzakajairika muexons 18-21 yeEGFR gene mumasamples kubva kuvanhu vasiri diki cell cancer yemapapu varwere.
-
Munhu ROS1 Fusion Gene Mutation
Iyi kit inoshandiswa ku in vitro qualitative yekuongorora yemhando gumi neina dzeROS1 fusion gene mutations mumunhu asiri diki cell cancer cancer samples (Tafura 1). Mhedzisiro yekuongororwa ndeyekuongororwa kwekiriniki chete uye haifanirwe kushandiswa seyoga hwaro hwekurapwa kwega kwevarwere.
-
Munhu EML4-ALK Fusion Gene Mutation
Kiti iyi inoshandiswa kuona zvine mutsindo mhando gumi nembiri dzeEML4-ALK fusion gene mumasampuli evarwere vekenza yemapapu emunhu asiri diki. Mhedzisiro yekuongororwa ndeyekuongororwa kwekiriniki chete uye haifanirwe kushandiswa seyoga hwaro hwekurapwa kwega kwevarwere. Varapi vanofanira kuita mutongo wakakwana pamusoro pezvabuda pabvunzo zvichibva pazvinhu zvakaita semamiriro emurwere, zviratidzo zvemushonga, mhinduro yekurapa, uye zvimwe zviratidzo zvemurabhoritari.
-
Mycoplasma Hominis Nucleic Acid
Iyi kit inokodzera kutariswa kwemhando yeMycoplasma hominis (MH) mumurume weti weti uye yevakadzi gital tract secretion samples.
-
Herpes Simplex Virus Type 1/2，(HSV1/2) Nucleic Acid
Kit iyi inoshandiswa pakuongorora in vitro qualitative diagnosis yeHerpes Simplex Virus Type 1 (HSV1) neHerpes Simplex Virus Type 2 (HSV2) kubatsira kuongorora nekurapa varwere vanenge vachifungidzirwa kuti vane utachiona hweHSV.
-
Yellow Fever Virus Nucleic Acid
Kiti iyi yakakodzera kutariswa kweYellow Fever virus nucleic acid muserum samples dzevarwere, uye inopa nzira dzinoshanda dzekubatsira kuongororwa uye kurapwa kweYellow Fever virus. Mhedzisiro yekuongororwa ndeyekuongororwa kwekiriniki chete, uye kuongororwa kwekupedzisira kunofanirwa kutariswa zvizere mukubatana pamwe nezvimwe zviratidzo zvekiriniki.
-
HIV Quantitative
HIV Quantitative Detection Kit (Fluorescence PCR) (inozozivikanwa sekiti) inoshandiswa pakuonekwa kwehuwandu hwehutachiona hwehutachiona hwehutachiona hweHIV (HIV) RNA muserum yevanhu kana sampuli dzeplasma.
-
Candida Albicans Nucleic Acid
Iyi kit inoitirwa kuti in vitro ionekwe Candida Albicans nucleic acid mukubuda kwemukadzi uye sputum samples.
-
Middle East Respiratory Syndrome Coronavirus Nucleic Acid
Iyo kit inoshandiswa pakuonekwa kwemhando yeMERS coronavirus nucleic acid mu nasopharyngeal swabs ine Middle East Respiratory Syndrome (MERS) coronavirus.
-
14 Mhando dzeHPV Nucleic Acid Typing
Human Papillomavirus (HPV) ndeyemhuri yePapillomaviridae yediki-morekuru, isina-enveloped, denderedzwa yakaviri-stranded DNA virus, ine genome urefu hunosvika 8000 base pairs (bp). HPV inotapurira vanhu kuburikidza nekubata zvakananga kana zvisina kunanga nezvinhu zvine utachiona kana kutapurirana pabonde. Utachiona hahuna kungobata-chaiyo chete, asiwo matishu-chaiwo, uye hunogona kungobata ganda remunhu uye mucosal epithelial masero, zvichikonzera zvakasiyana-siyana zvepillomas kana warts muganda remunhu uye kukuvadza kunowedzera kune yekubereka turakiti epithelium.
Kiti iyi inokodzera in vitro qualitative typing yekuona mhando gumi neina dzepapillomaviruses dzevanhu (HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68) nucleic samples dzechikadzi uye weti yevakadzi swab samples. Inogona kupa chete nzira dzekubatsira dzekuongororwa uye kurapwa kwehutachiona hweHPV.
-
19 Mhando dzeKufema Pathogen Nucleic Acid
Kiti iyi inoshandiswa kusanganisa kucherechedzwa kwehutano hweSARS-CoV-2, hutachiona hwefuruwenza A, hutachiona hwefuruwenza B, adenovirus, mycoplasma pneumoniae, chlamydia pneumoniae, kufema syncytial virus uye parainfluenza virus (Ⅰ, II, III, IV) muhuro swabs uye sputumphimophie sampuli, sputumphimovirus mumunhu streptococcus pneumoniae, klebsiella pneumoniae, staphylococcus aureus, pseudomonas aeruginosa, legionella pneumophila uye acinetobacter baumannii.
